Geode Capital Management’s HTG Molecular Diagnostics, Inc. Common Stock HTGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $28K | Hold |
|
|||||
|
2022
Q2 | $48K | Buy |
|
|||||
|
2022
Q1 | $63K | Hold |
|
|||||
|
2021
Q4 | $249K | Hold |
|
|||||
|
2021
Q3 | $262K | Sell |
|
|||||
|
2021
Q2 | $273K | Buy |
|
|||||
|
2021
Q1 | $191K | Hold |
|
|||||
|
2020
Q4 | $167K | Buy |
|
|||||
|
2020
Q3 | $127K | Hold |
|
|||||
|
2020
Q2 | $277K | Hold |
|
|||||
|
2020
Q1 | $125K | Hold |
|
|||||
|
2019
Q4 | $270K | Buy |
|
|||||
|
2019
Q3 | $165K | Hold |
|
|||||
|
2019
Q2 | $404K | Buy |
|
|||||
|
2019
Q1 | $596K | Buy |
|
|||||
|
2018
Q4 | $553K | Buy |
|
|||||
|
2018
Q3 | $956K | Hold |
|
|||||
|
2018
Q2 | $617K | Buy |
|
|||||
|
2018
Q1 | $660K | Buy |
|
|||||
|
2017
Q4 | $40K | Hold |
|
|||||
|
2017
Q3 | $33K | Hold |
|
|||||
|
2017
Q2 | $52K | Hold |
|
|||||
|
2017
Q1 | $137K | Hold |
|
|||||
|
2016
Q4 | $44K | Hold |
|
|||||
|
2016
Q3 | $46K | Hold |
|
|||||
|
2016
Q2 | $51K | Hold |
|
|||||
|
2016
Q1 | $56 | Hold |
|
|||||
|
2015
Q4 | $86K | Hold |
|
|||||
|
2015
Q3 | $151K | Buy |
|